Ad
Search
Generic filters
Filter by content type
Taxonomy terms

RMED

🔒

Subscribe for full access

Unlock Industry-grade Shariah Compliance for US, UK, Canada, Germany, GCC, Europe and India. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.

Get started from just $1/month

Ad

Recommendation Rating

1.5

1

2

3

4

5

1 = STRONG BUY | 2 = BUY | 3 = HOLD | 4 = UNDERPERFORM | 5 = SELL

Analysts’ Price Targets

Mean 6.55

Low: 1.1

High: 12

Total Analysts: 1

Company Profile

Ra Medical Systems, Inc. is a medical device company that leverages its excimer laser-based platform for use in the treatment of vascular immune-mediated inflammatory diseases. The Company’s excimer laser and single-use catheter system, Destruction of Arteriosclerotic Blockages by laser Radiation Ablation (DABRA), is used as a tool in the treatment of peripheral artery disease (PAD), which commonly occurs in the legs. DABRA is used by physicians as a tool in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease, a form of PAD, both above- and below-the-knee. DABRA breaks down plaque to proteins, lipids, and other chemical compounds, thereby eliminating blockages. DABRA is predominantly used as an adjunct therapy with angioplasty balloons, drug-coated balloons, stents, and other endovascular treatments. DABRA employs photoablation to remove cross-blockages by breaking the bonds of the obstructing plaque directly.

We do our best to screen stocks as accurately as possible. Please let us know in the comments if you spot an error or find something questionable. Jazaak Allahu khairan

Ad

Responses